+ Chinese + English

Home page

Fluoro-modified nucleosides

Halo-nucleosides

2’-Modified nucleosides

3’-Modified nucleosides

4’-Modified nucleosides

5’-Modified nucleosides

3’-Deoxy nucleosides

2’,3’-Dideoxy nucleosides

Didehydro-nucleosides

Azido-nucleosides

Amino nucleosides

Thio-nucleosides

Iso-cytidine derivatives

Iso-guanosine derivatives

Arabino-nucleosides

Xylo-nucleosides

2-Modified purine nucleosides

6-Modified purine nucleosides

6-De-aminopurine nucleosides

8-Modified purine nucleosides

7-Deaza-purine nucleosides

8-Aza-7-deaza-purine nucleosides

5,6-Dihydro-uridines

3-Deazauridines

4-Deoxypyrimidine nucleosides

5-Modified pyrimidine nucleosides

6-Modified pyrimidine nucleosides

Anhydro-nucleosides

Pyridine nucleosides

Tricyclic nucleosides

Morpholino-nucleosides

N-Methylated nucleosides

Naturally modified ribo-nucleosides

Phosphorus-containing nucleotides

Alpha-Nucleosides

Protected nucleosides with NH2/OH open

Other modified nucleosides

+011-86-371-86026726

Nucleoside Derivatives

Home page > Products > Nucleoside Derivatives > 5’-Modified nucleosides

GL100957
Catalog No. GL100957 Name 4’,5’-Didehydro-5’-deoxyuridine Synonyms 1-(5-Deoxy-b-D-erythro-pent-4-enofuranosyl)uracil Formula C9H10N2O5 FW 226.19 CAS No. 14365-63-0 Purity ≥ 95% Property Package Packed as desired Classification Nucleoside Derivatives – 5’-Modified nucleosides Notes:

: About Granlen | News and Events | Infrastructure | Culture & Career | Contact Us |

© 1998 - 2017 Granlen Inc. All Rights Reserved 豫ICP备13010571号-1